Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zeus Shield
- Development stage
- Preclinical
- Lead developer
- Wellington Zhaotai Therapies
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, TCR-Engineered T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
Zeus Shield is an experimental cell therapy series being developed by Wellington Zhaotai Therapies for the treatment of lung cancer. This program utilizes both T cell and Natural Killer (NK) cell modalities within the company's anti-cancer cell immunotherapy platform. Currently in the preclinical stage, the therapy aims to harness the cytotoxic potential of these immune cells to specifically target and eliminate lung cancer cells. The program is part of a broader series of cell-based immunotherapies designed to leverage the innate and adaptive immune systems to combat solid tumors.
- Other names
- Zeus Shield (Lung Cancer)
Beyond the preview
Go deeper on Zeus Shield.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zeus Shield.